Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

Publicado en línea: 29 mar 2023

Páginas: 11 - 16

Recibido: 20 oct 2022

Aceptado: 14 feb 2023

DOI: https://doi.org/10.2478/amma-2023-0009

Palabras clave

congenital heart disease, tetralogy of Fallot, pentalogy of Fallot, blood biomarkers, pulmonary valve replacement

© 2023 Milla Marika Kainlauri et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.